GR1000378B - Μεθοδος παρασκευης βενζοετεροκυκλικων σουλφονων - Google Patents

Μεθοδος παρασκευης βενζοετεροκυκλικων σουλφονων

Info

Publication number
GR1000378B
GR1000378B GR900100068A GR900100068A GR1000378B GR 1000378 B GR1000378 B GR 1000378B GR 900100068 A GR900100068 A GR 900100068A GR 900100068 A GR900100068 A GR 900100068A GR 1000378 B GR1000378 B GR 1000378B
Authority
GR
Greece
Prior art keywords
alkyl
formula
ring
group
novel compounds
Prior art date
Application number
GR900100068A
Other languages
English (en)
Other versions
GR900100068A (en
Inventor
David Robert Brittain
Michael Thomas Cox
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898902410A external-priority patent/GB8902410D0/en
Priority claimed from GB898902407A external-priority patent/GB8902407D0/en
Application filed by Ici Plc filed Critical Ici Plc
Publication of GR900100068A publication Critical patent/GR900100068A/el
Publication of GR1000378B publication Critical patent/GR1000378B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/08—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Η ευρεσιτεχνία αφορά νέες φαρμακευτικώς χρήσιμες, βενζοετεροκυκλικές σουλφόνες του τύπου Ι: ω
GR900100068A 1989-02-03 1990-02-05 Μεθοδος παρασκευης βενζοετεροκυκλικων σουλφονων GR1000378B (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898902410A GB8902410D0 (en) 1989-02-03 1989-02-03 Bicyclic compounds
GB898902407A GB8902407D0 (en) 1989-02-03 1989-02-03 Heterocyclic compounds

Publications (2)

Publication Number Publication Date
GR900100068A GR900100068A (en) 1991-06-28
GR1000378B true GR1000378B (el) 1992-06-30

Family

ID=26294911

Family Applications (1)

Application Number Title Priority Date Filing Date
GR900100068A GR1000378B (el) 1989-02-03 1990-02-05 Μεθοδος παρασκευης βενζοετεροκυκλικων σουλφονων

Country Status (12)

Country Link
US (1) US5185452A (el)
EP (1) EP0409949B1 (el)
JP (1) JPH04504250A (el)
AT (1) ATE105837T1 (el)
AU (1) AU631602B2 (el)
CA (1) CA2025768A1 (el)
DE (1) DE69008956D1 (el)
GR (1) GR1000378B (el)
IL (1) IL93178A0 (el)
NZ (1) NZ232349A (el)
PT (1) PT93052A (el)
WO (1) WO1990008763A1 (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11106381A (ja) * 1997-09-30 1999-04-20 Ss Pharmaceut Co Ltd クロメン誘導体及びその塩並びにこれを含有する医薬
US7620437B2 (en) * 2005-06-03 2009-11-17 Abbott Diabetes Care Inc. Method and apparatus for providing rechargeable power in data monitoring and management systems
JP2011043839A (ja) * 2010-09-29 2011-03-03 Panasonic Corp レジスト材料及びそれを用いたパターン形成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1229653A (el) * 1968-03-14 1971-04-28
US3882247A (en) * 1972-04-21 1975-05-06 Du Pont Fungicidal nitro organic sulfur compounds
US4053633A (en) * 1976-06-24 1977-10-11 The Dow Chemical Company Aryl dibromonitromethyl sulfones
US4670470A (en) * 1979-08-15 1987-06-02 Merck & Co., Inc. Allylsulfoxide enzyme inhibitors
US4309554A (en) * 1980-04-28 1982-01-05 The Dow Chemical Company 3-(2-Thiophenesulfonyl)-2-halopropanenitriles
JPS5740478A (en) * 1980-08-22 1982-03-06 Ono Pharmaceut Co Ltd Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative
DE3326635A1 (de) * 1983-07-23 1985-01-31 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von monomethylsubstituierten methylen-verbindungen
GB8718619D0 (en) * 1987-08-06 1987-09-09 Ici Plc Pharmaceutical compositions
GB8810203D0 (en) * 1988-04-29 1988-06-02 Ici Plc Heterocyclic compounds

Also Published As

Publication number Publication date
AU631602B2 (en) 1992-12-03
JPH04504250A (ja) 1992-07-30
EP0409949B1 (en) 1994-05-18
CA2025768A1 (en) 1990-08-04
US5185452A (en) 1993-02-09
EP0409949A1 (en) 1991-01-30
IL93178A0 (en) 1990-11-05
NZ232349A (en) 1992-06-25
ATE105837T1 (de) 1994-06-15
PT93052A (pt) 1990-08-31
AU5030890A (en) 1990-08-24
WO1990008763A1 (en) 1990-08-09
GR900100068A (en) 1991-06-28
DE69008956D1 (de) 1994-06-23

Similar Documents

Publication Publication Date Title
HUT54357A (en) Process for producing benzilidene-(azolylmethyl)-cycloalkane and -cycloalkene derivatives, fungicidal compositions comprising such compounds as active ingredient and intermediates usable for the production of the active ingredients
HU912485D0 (en) Process for producing diazines
HU907105D0 (en) Process for producing new polypeptones
HUT57767A (en) Process for producing purine derivatives and pharmaceutical compositions comprising same
HUT56092A (en) Process for producing 2-amino-pyrimidine-4-carboxamide derivatives and pharmaceutical compositions containing them
ZA904196B (en) Process for the preparation of a pharmaceutical composition for the treatment of autoimmune diseases
ES478871A1 (es) Un procedimiento de preparacion de 2,6-dialcoxibenzamidas.
SE8802008L (sv) Mellanprodukt foer framstaellning av fluorometyltiooxacefalosporiner
GR1000378B (el) Μεθοδος παρασκευης βενζοετεροκυκλικων σουλφονων
HU9201610D0 (en) Method for producing 2-hydroxi-2-phenyl-ethyl-amino compounds
AU625886B2 (en) New oxazolopyridine derivatives, process for preparing them and pharmaceutical compositions containing them
HUT43594A (en) Process for production of new derivatives of izoxasole and medical compounds containing thereof
DE69006274D1 (de) Heterozyklische sulphonylnitromethane, verfahren zu deren herstellung und pharmazeutische zusammensetzungen.
ZA896617B (en) Sulphonamides,processes for their preparation and pharmaceutical compositions
AU3376193A (en) The use of xanthine derivatives for the treatment of muscle damage after interruption of the blood circulation
HUT39158A (en) Process for preparing carbacyclines and pharmaceutical compositions containing such compounds
TW349945B (en) Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic
GR3033175T3 (en) Trifluoromethylsulfonylphenyl or trifluoromethylsulfinylphenyl group containing 2-cyano-3-hydroxy-propenamide derivatives, process for their preparation, their use as medicaments and pharmaceutical compositions containing them
DE3470741D1 (en) Azolylmethylcycloacetals, process for their preparation and their use as medicaments
AU6703090A (en) New substituted benzothiazolinones, process for preparing these and pharmaceutical compositions containing them